Geron GERN
NASDAQ GERN
$1.16 -0.08 (-6.45%)
At close: Oct 21, 2026 · 4:00 PM EDT

Geron (GERN) Restructuring Costs (2012 - 2026)

Updated

Geron (GERN) recorded Restructuring Costs of -$157,000 in Q2 2026.

Analysis

Geron (GERN) Restructuring Costs (2012 - 2026) Analysis & Trends

On a TTM basis, Geron's Restructuring Costs came in at -$551,000 as of Jun 30, 2026; for FY2025, it was $17.03 million.

  • The Q2 2026 figure is the highest quarterly Restructuring Costs since Q3 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Geron 763.84 Mn -587.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -157,000.00
Mar 31, 2026 -394,000.00
Sep 30, 2015 -41,000.00
Jun 30, 2015 941,000.00
Mar 31, 2015 406,000.00
Dec 31, 2013 430,000.00
Sep 30, 2013 116,000.00
Jun 30, 2013 838,000.00
Dec 31, 2012 2.70 Mn
API Access

Geron Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=GERN&period=max&api_key=YOUR_API_KEY